Literature DB >> 1722247

Occult regional lymph node metastases from breast carcinoma: immunohistological detection with antibodies CAM 5.2 and NCRC-11.

M H Galea1, E Athanassiou, J Bell, B Dilks, J F Robertson, C W Elston, R W Blamey, I O Ellis.   

Abstract

Ninety-eight consecutive patients with primary operable breast cancer and an initial diagnosis of no regional lymph node metastases as assessed by conventional light microscopy were studied. Immunohistological staining of routine lymph node sections was assessed using two monoclonal antibodies: CAM 5.2 (Becton Dickinson) with specificity for low molecular weight cytokeratin, and NCRC-11 (CRC Laboratories, Nottingham) with specificity for epithelial mucin antigen. Positive staining for occult metastases was seen in nine patients with CAM 5.2 and in eight of these nine with NCRC-11. At a follow-up out to 14 years, there was no difference in overall survival, in recurrence-free survival, or in frequency of or time to presentation of local or regional recurrences between occult metastasis-positive and occult metastasis-negative patients. This study concludes that while immunohistological staining of routine lymph node sections increases the diagnostic yield of metastases, it is not to be recommended as this increase is of no useful clinical value.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722247     DOI: 10.1002/path.1711650305

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  The Nottingham Prognostic Index in primary breast cancer.

Authors:  M H Galea; R W Blamey; C E Elston; I O Ellis
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

3.  Prognostic factors in primary breast carcinoma.

Authors:  S E Pinder; I O Ellis; C W Elston
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

4.  Benign lymph node inclusions mimicking metastatic carcinoma.

Authors:  A G Douglas-Jones
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

5.  Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in "node-negative" colorectal cancer.

Authors:  M Sasaki; H Watanabe; J R Jass; Y Ajioka; M Kobayashi; K Matsuda; K Hatakeyama
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

6.  Preliminary investigation of intraperitoneal raltitrexed in patients with gastric cancer.

Authors:  Ping Zhao; Zhi Ding; Lingchao Tang; Xiang Zhou
Journal:  World J Surg Oncol       Date:  2014-12-30       Impact factor: 2.754

7.  Occult axillary node metastases in breast cancer: their detection and prognostic significance.

Authors:  M A McGuckin; M C Cummings; M D Walsh; B G Hohn; I C Bennett; R G Wright
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

8.  Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients.

Authors:  I de Mascarel; G MacGrogan; V Picot; S Mathoulin-Pelissier
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

9.  Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancer.

Authors:  Hang Yuan; Bo'an Zheng; Shiliang Tu
Journal:  World J Surg Oncol       Date:  2015-11-24       Impact factor: 2.754

10.  Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.

Authors:  Guixin Wang; Shuhao Zhang; Meiling Wang; Lin Liu; Yaqian Liu; Lianjun Tang; He Bai; Haidong Zhao
Journal:  BMC Cancer       Date:  2021-07-30       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.